BerGenBio reports third quarter 2022 financial results and provides business update

Corporate Breaking News

Home : BerGenBio reports third quarter 2022 financial results and provides business update

Nov 15 2022	BerGenBio reports third quarter 2022 financial results and provides business update
- Randomized first patient in the Phase 2b EU-SolidAct platform for hospitalized COVID-19 patients - - Initiated Phase 1b/2a trial in 1st line NSCLC patients harboring STK11 mutations - - Strengthened financial position with support from largest shareholder - BERGEN, Norway, Nov. 15, 2022...


Source:https://www.prnewswire.com:443/news-releases/bergenbio-reports-third-quarter-2022-financial-results-and-provides-business-update-301677958.html

Related News
» XCA 2600, World's Strongest All-Terrain Crane Developed by XCMG, Sets New Wind Power Hoisting Record » ALPINION MEDICAL SYSTEMS LANZA LA MEJOR CONSOLA 'X-CUBE 90 on GPX' Y VALUE CONSOLE 'X-CUBE 60' EN RSNA 2022